Diagnostics News and Research

RSS

Fujirebio, Thermo Fisher sign license agreement for broad availability of PCT testing

Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed a long-term license agreement with Fujirebio Inc. to make its biomarker assay Procalcitonin (PCT) available on the Lumipulse family of laboratory instruments, using the chemiluminescent enzyme immunoassay (CLEIA) technology.

From Thermo Fisher Scientific Inc. 21 Nov 2012

Novartis receives FDA approval for Flucelvax to prevent seasonal influenza

The U.S. Food and Drug Administration announced today the approval of Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal cells, instead of fertilized chicken eggs. Flucelvax is approved to prevent seasonal influenza in people ages 18 years and older.

21 Nov 2012

Emory University, Georgia Tech to establish Malaria Host-Pathogen Interaction Center

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a five-year contract of up to $19.4 million, depending on contract options exercised, to establish the Malaria Host-Pathogen Interaction Center (MaHPIC).

20 Nov 2012

USPTO issues Notice of Allowance to Sanovas’ nested balloon catheter

Sanovas, Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company's nested balloon catheter for localized drug delivery, a component of Sanovas' Vas Zeppelin Smart Catheter technology portfolio.

20 Nov 2012

HORIBA Europe opens new R&D facility

HORIBA Europe has inaugurated its new research and technology center at the Saclay Technopole. Atsushi Horiba, President of the HORIBA Group, cut the ribbon opening the doors to HORIBA’s home for scientific innovation and cooperation.

19 Nov 2012

Abacus Diagnostica’s GenomEra C. difficile assay receives CE mark

Abacus Diagnostica Ltd announced that it has received the CE mark for the GenomEra C. difficile assay for the detection of toxin-producing Clostridium difficile directly from stool samples. C. difficile is the leading cause of infectious nosocomial diarrhea in Europe and North America.

19 Nov 2012

Carl Zeiss Meditec introduces new family of OCT products at 2012 AAO-APAO Joint Meeting

Medical technology manufacturer Carl Zeiss Meditec introduced a new family of OCT products spanning the full spectrum of multi-modality imaging for retinal disease and glaucoma at the 2012 Joint Meeting of the American Academy of Ophthalmology and the Asia-Pacific Academy of Ophthalmology in Chicago.

17 Nov 2012

Springer to introduce new book series on healthcare in collaboration with EPMA

Springer will launch a new book series in collaboration with the European Association for Predictive, Preventive and Personalised Medicine.

17 Nov 2012

St. Luke's unveils Discovery IGS 730 Hybrid OR from GE Healthcare

St. Luke's University Hospital unveiled the Discovery IGS 730 Hybrid OR from GE Healthcare today, becoming the first hospital in the United States to offer this exciting new technology.

17 Nov 2012

Thermo Fisher announces opening of new facility in Suzhou, China

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The facility expands the company's global manufacturing footprint and establishes local production capabilities to meet increased customer demand in China and other Asia-Pacific markets.

From Thermo Fisher Scientific Inc. 16 Nov 2012

Cool cut specimen clamp from Thermo Scientific maintains block temperature for better quality sections

The Thermo Scientific Cool Cut specimen clamp maintains block temperature for more consistent, better quality sections.

From Thermo Fisher Scientific Inc. 15 Nov 2012

Enrollment complete in Exact Sciences DeeP-C screening trial for colorectal cancer

Exact Sciences Corp. today announced it has completed patient enrollment in its DeeP-C pivotal trial for colorectal cancer screening. The study enrolled more than 12,700 patients at sites in the United States and Canada.

15 Nov 2012

Courtagen, AGBL enter exclusive distribution agreement for clinical tests

Courtagen Life Sciences Inc. announced today they have signed an exclusive strategic distribution agreement with the Alliance Global Group (AGBL) to help clinicians in emerging markets diagnose and manage a number of genetically based disorders.

15 Nov 2012

RainDance's ThunderStorm System for targeted sequencing selected by UCL Cancer Institute

RainDance Technologies, Inc., the Digital Biology Company, today announced that the University College London (UCL) Cancer Institute has adopted its ThunderStorm System as a centralized platform for the validation of genomic and epigenomic targets from clinical and non-clinical studies, including follow-ups for genome-wide and epigenome-wide association studies (GWAS and EWAS), as well as stratified cancer medicine and basic research.

15 Nov 2012

FDA accepts Navidea’s resubmitted NDA for Lymphoseek

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the Company's October 30, 2012 resubmission of its New Drug Application (NDA) for Lymphoseek (Technetium Tc 99m Tilmanocept) Injection.

14 Nov 2012

Abbott releases details on phase 3 hepatitis C registrational program

Abbott today released details on its phase 3 hepatitis C registrational program following promising results from its phase 2b clinical trial, known as Aviator, presented at the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) in Boston.

13 Nov 2012

Could lactate levels in amniotic fluid help diagnose dysfunctional labour?

With as many as a 30 percent of pregnant women in Australia experiencing a caesarean birth, a study led by researchers from the University of Sydney aims to determine if there is a link between high levels of lactate in amniotic fluid and difficult labours which may end with a caesarean section.

13 Nov 2012

Radiotherapy protocol deviations: an interview with Dr Nitin Ohri

Radiotherapy is a key component of cancer therapy. A majority of cancer patients get radiotherapy in some form at some point in their disease course. It can be used in a curative setting or in a palliative setting.

12 Nov 2012

Boulder Diagnostics launches novel SpiroFind test to detect Lyme disease

Boulder Diagnostics Inc. announced today the European market launch of the CE marked SpiroFind in vitro diagnostic test for the detection of active Lyme Borreliosis. The SpiroFind test is offered as a diagnostic service by the company's clinical diagnostic service laboratory in Mellrichstadt, Germany.

9 Nov 2012

Elevated ST2 biomarker levels strongly indicate heart failure and mortality in HIV patients

Critical Diagnostics, makers of the Presage ST2 Assay, announced today that during a presentation at the American Heart Association Scientific Sessions in Los Angeles, the results of a study demonstrated that elevated levels of the biomarker ST2 in HIV patients was strongly indicative of the development of heart failure and mortality.

9 Nov 2012